Umeå universitets logga

umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
K2S2O8-mediated aerobic oxidative coupling of 6-amino-7-(aminomethyl)-thiazolino-pyridones with aldehydes: Direct access to highly functionalized pyrimidine fused thiazolino-2-pyridones with amyloid fibril binding activity or inhibitors of Amyloid-β fibril formation
(Fredrik Almqvist)
Umeå universitet, Teknisk-naturvetenskapliga fakulteten, Kemiska institutionen.
Umeå universitet, Medicinska fakulteten, Institutionen för medicinsk kemi och biofysik.
Umeå universitet, Teknisk-naturvetenskapliga fakulteten, Kemiska institutionen. (Fredrik Almqvist)
Visa övriga samt affilieringar
(Engelska)Manuskript (preprint) (Övrigt vetenskapligt)
Abstract [en]

We herein present the synthesis of diversely functionalized pyrimidine fused thiazolino-2-pyridones via K2S2O8-mediated oxidative coupling of 6-amino-7-(aminomethyl)- thiazolino-2-pyridones with aldehydes. The developed protocol is mild, has wide substrate scope, and does not require transition metal catalyst or base. Some of the synthesized compounds have the ability to inhibit the formation of Amyloid-β fibrils associated with Alzheimer's disease, while others bind to mature Amyloid-β and α-Synuclein fibrils.

Nationell ämneskategori
Organisk kemi
Identifikatorer
URN: urn:nbn:se:umu:diva-174534OAI: oai:DiVA.org:umu-174534DiVA, id: diva2:1461483
Tillgänglig från: 2020-08-26 Skapad: 2020-08-26 Senast uppdaterad: 2020-08-27
Ingår i avhandling
1. Synthesis of Ring-fused Peptidomimetics: Interacting with Amyloid Fibrils
Öppna denna publikation i ny flik eller fönster >>Synthesis of Ring-fused Peptidomimetics: Interacting with Amyloid Fibrils
2020 (Engelska)Doktorsavhandling, sammanläggning (Övrigt vetenskapligt)
Abstract [en]

Parkinson's and Alzheimer's disease are the two most common neurological disorders in humans. Both conditions involve progressive death of neurons in the central nervous system, decline in bodily functions and eventually (and invariably), death. So far, no cure exists and the available treatments can only ease symptoms. Despite substantial investments in research, the biomolecular processes are still far from fully understood. However, both diseases are associated with formation of fibrillar protein aggregates called amyloid deposits. Whereas Alzheimer’s disease involves aggregation of the Tau and Amyloid β proteins, α-Synuclein fibrilization plays a key role in Parkinson's disease. Although they are chemically distinct, the deposits consist of protein fibres with similar morphology and fold. Small molecules, such as the thiazoline fused 2-pyridones herein presented, can interfere with the formation of amyloid fibres, or bind to them. Besides having potential for diagnostication and treatment, such small molecules constitute valuable tool compounds in future research, to unravel the mechanisms of amyloid formation and pathology. The first step towards successful treatment, diagnostication and prevention of Alzheimer's and Parkinson's disease is understanding the causes and underlying mechanisms better. This thesis narrates the synthesis and development of novel chemical structures: multi ring fused peptidomimetics with the ability to bind mature amyloid fibrils, consisting of α-Synuclein or Amyloid β. 

The first project (articles I, III and VI) describes method development for the extension of bicyclic thiazolino 2-pyrdiones by fusion with aromatic nitrogen heterocycles, which enables the desired amyloid binding properties. Derivatisations of the newly generated central scaffold, and variation of the multiple attached substituents, were subsequently performed in efforts to improve binding strength and solubility, and gain selectivity towards certain fibrils. One of the most promising amyloid fibril binders was evaluated in a human cell line and in mice, and found to be protective against accelerator induced neurotoxicity. One pyrimidine fused compound moreover indicated potent inhibition of Amyloid b aggregation. The second project (articles II, IV and V) focuses on development of methods to modify the thiazoline ring. Ring opening induced by electrophiles generates N-alkenyl 2-pyridones but decreases amyloid binding potency. Introduction of a cyclobutane moiety fused with the thiazoline ring is better tolerated, and adds a terminal alkene moiety that can be exploited in future chemical modifications. Expansion of the five membered thiazoline ring to a six membered dihydrothiazine ring, equipped with a nitrophenyl substituent, provides compounds with enhanced fibril binding capacity, which further inhibits Amyloid β fibril formation in vitro. Taken together, the synthetic methodologies allow construction and late stage modification of complex fused heterocycles, with several points of variation. Thus, the developed methods may be of future value in our laboratories and elsewhere.

Ort, förlag, år, upplaga, sidor
Umeå: Umeå Universitet, 2020. s. 128
Nyckelord
organic chemistry, synthesis, peptidomimetics, thiazoline fused 2-pyridones, Alzheimer's disease, Parkinson's disease, Amyloid, Amyloid-beta, alfa-Synuclein, method development
Nationell ämneskategori
Organisk kemi
Forskningsämne
organisk kemi
Identifikatorer
urn:nbn:se:umu:diva-174405 (URN)978-91-7855-351-8 (ISBN)978-91-7855-352-5 (ISBN)
Disputation
2020-09-18, Lilla hörsalen, KBC KB E3 01, Umeå Universitet, Linnaeus väg 10, 907 36, Umeå, 15:28 (Engelska)
Opponent
Handledare
Forskningsfinansiär
Knut och Alice Wallenbergs Stiftelse, KAW 2013.0031Kempestiftelserna, SMK-1755Göran Gustafssons stiftelse för naturvetenskaplig och medicinsk forskning (KVA)NIH (National Institute of Health), R01AI134847-01A1Stiftelsen för strategisk forskning (SSF), SB12-0070
Anmärkning

Tackar även Forskningsrådet (Swedish Research Council) (2014-04673; 2014-04673; 2017-00695; 2017-02339; 2018-04589), Michael J. Fox Foundation och Erling Perssons stiftelse som ej finns med i listan nedan.

Errata: Digitalt ISBN saknas i tryckt och digital version. 

Tillgänglig från: 2020-08-28 Skapad: 2020-08-25 Senast uppdaterad: 2022-10-31Bibliografiskt granskad

Open Access i DiVA

Fulltext saknas i DiVA

Person

Ådén, JörgenGharibyan, AnnaAdolfsson, Dan E.Vielfort, KatarinaSingh, PardeepBergström, SvenOlofsson, AndersAlmqvist, Fredrik

Sök vidare i DiVA

Av författaren/redaktören
Ådén, JörgenGharibyan, AnnaAdolfsson, Dan E.Vielfort, KatarinaSingh, PardeepBergström, SvenOlofsson, AndersAlmqvist, Fredrik
Av organisationen
Kemiska institutionenInstitutionen för medicinsk kemi och biofysikUmeå Centre for Microbial Research (UCMR)Institutionen för molekylärbiologi (Medicinska fakulteten)Molekylär Infektionsmedicin, Sverige (MIMS)
Organisk kemi

Sök vidare utanför DiVA

GoogleGoogle Scholar

urn-nbn

Altmetricpoäng

urn-nbn
Totalt: 443 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf